Form 4: SI-BONE Legal Officer Sells 400 Shares Under 10b5-1 Plan

SI-BONE's SVP, Ops & Adm/Chief Legal Officer, Michael A. Pisetsky, sold 400 shares of common stock for $20 per share on November 24, 2025, as part of a pre-arranged trading plan.

Summary

• Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Officer of SI-BONE, Inc. (SIBN), reported a sale of common stock.
• The transaction involved the disposition of 400 shares of common stock.
• The shares were sold at a price of $20 per share.
• The sale occurred on November 24, 2025.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan established on June 13, 2025.
• Following the sale, Mr. Pisetsky beneficially owns 251,496 shares, which includes 125,823 shares issuable upon settlement of restricted stock units.

Sentiment

Score: 5

Explanation: The transaction is a routine, pre-planned insider sale under a 10b5-1 plan, which is generally considered neutral. While any insider sale can be viewed with slight caution, the pre-planned nature mitigates negative sentiment. The small number of shares relative to total holdings also suggests minimal impact.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the officer's direct equity stake in the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide information directly related to broader industry trends or competitive landscape. It reflects an individual officer's equity management.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but the pre-planned nature suggests no new negative sentiment. The total beneficial ownership remains substantial.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled sale of a relatively small number of shares by an executive under a 10b5-1 plan. Such transactions are typically for personal financial planning and do not reflect a change in the company's fundamentals or the executive's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

SI-BONE, SIBN, Insider Trading, Form 4, Stock Sale, Michael A. Pisetsky, 10b5-1 Plan, Corporate Officer, Equity Transaction